Mitoxantrone and thrombocytopenia Patient Reports February 12, 2012

Mitoxantrone Side Effects Report #5022371-8
Mitoxantrone side effect was reported by a Consumer or non-health professional from FRANCE on May 19, 2006. Female patient, 51 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, chromosome abnormality, haemorrhagic disorder, lung disorder, neutropenia, septic shock, thrombocytopenia. Mitoxantrone dosage: 20 MG. During the same period patient was treated with AZATHIOPRINE, INTERFERON BETA. Patient died on 12/13/2001.

Mitoxantrone Side Effects Report #4551061-0
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Dec 22, 2004. Female patient, 39 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: neutropenia, normochromic normocytic anaemia, thrombocytopenia. Mitoxantrone dosage: unknown. Patient recovered.

Mitoxantrone Side Effects Report #5232282-0
Mitoxantrone side effect was reported by a Consumer or non-health professional from ITALY on Jan 23, 2007. Female patient, 37 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, anaemia, hepatomegaly, leukopenia, pallor, thrombocytopenia. Mitoxantrone dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, INTERFERON BETA. Patient recovered.

Mitoxantrone Side Effects Report #4995469-8
Mitoxantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2006. Female patient was diagnosed with lymphoma  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: haematotoxicity, thrombocytopenia. Mitoxantrone dosage: 10 MG/M 2; EVERY 4 WK. During the same period patient was treated with DEXAMETHASONE, RITUXIMAB, FLUDARABINE PHOSPHATE. Patient recovered.


Mitoxantrone Side Effects Report #4995470-4
Mitoxantrone side effect was reported by a Physician from UNITED STATES on Apr 20, 2006. Female patient was diagnosed with lymphoma  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: haematotoxicity, thrombocytopenia. Mitoxantrone dosage: 10 MG/M2; EVERY 4 WK. During the same period patient was treated with DEXAMETHASONE, RITUXIMAB, FLUDARABINE PHOSPHATE. Patient recovered.

Mitoxantrone Side Effects Report #4995472-8
Mitoxantrone side effect was reported by a Physician from UNITED STATES on Apr 20, 2006. Female patient was diagnosed with lymphoma  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: haematotoxicity, thrombocytopenia. Mitoxantrone dosage: 10 MG/M2; EVERY 4 WK. During the same period patient was treated with DEXAMETHASONE, RITUXIMAB, FLUDARABINE PHOSPHATE. Patient recovered.

Mitoxantrone Side Effects Report #4995473-X
Mitoxantrone side effect was reported by a Physician from UNITED STATES on Apr 20, 2006. Female patient was diagnosed with lymphoma  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: thrombocytopenia. Mitoxantrone dosage: 10 MG/M2; EVERY 4 WK. During the same period patient was treated with DEXAMETHASONE, RITUXIMAB, FLUDARABINE PHOSPHATE. Patient recovered.